SCARLETT BONE: Open Payments
NPI 1790274355 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,822 in 119 payments from 20 companies in 2025. Trend: 2023 $2,852 · 2024 $2,836 · 2025 $3,822
Food & beverage: $2,962Travel & lodging: $861
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $1,524 |
| Regeneron Healthcare Solutions, Inc. | 7 | $274 |
| Arcutis Biotherapeutics, Inc. | 3 | $259 |
| Organon LLC | 9 | $205 |
| Amgen Inc. | 10 | $182 |
| UCB, Inc. | 14 | $170 |
| Janssen Biotech, Inc. | 11 | $166 |
| Incyte Corporation | 10 | $162 |
| ABBVIE INC. | 8 | $154 |
| PFIZER INC. | 10 | $150 |
Products named: DUPIXENT, Zoryve, COSENTYX, OTEZLA, Bimzelx, TREMFYA, OPZELURA, CIBINQO.
Industry payments across AR — which companies pay providers there.
